Financials
- Market Capitalization 456.43 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.67
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.78 USD | -2.02% | -22.04% | -2.75% | +92.10% | 472.99 M USD | ||
| 2975 | OVID Ovid Therapeutics Inc. - Common Stock | 2.49 USD | +1.22% | -8.12% | +6.41% | +492.86% | 464.73 M USD | ||
| 2998 | CABA Cabaletta Bio, Inc. - Common Stock | 2.77 USD | +3.75% | -11.50% | -0.72% | +63.91% | 451.66 M USD | ||
| 3001 | EVMN Evommune, Inc. Common Stock | 12.45 USD | +3.75% | -10.50% | -38.46% | -28.12% | 448.43 M USD |